Open Accessibility Menu
Hide

Biospecimen Pathology Core

The Biospecimen Pathology Core will accomplish three aims:

  1. Provide annotated human biospecimens, including blood and tissue components
  2. Aid in the design and implementation of prospective specimen collection protocols and of histologic and molecular analyses of specimens
  3. Construct tissue microarrays tailored to individual and collaborative research projects

The accomplishment of these aims will enhance and facilitate translational research on a variety of cancers. In particular, verifying the quality of biospecimens will help to ensure the validity of research results. In addition, providing clinic-pathologic annotation of specimens will increase the relevance and significance of the various projects planned for Stephenson Cancer Center.

Equipment

  • Agilent SureScan Microarray Scanner System
  • ArrayIt® SpotWare™ Colorimetric Microarray Scanner
  • Biorad CFX96™ Touch Real-Time PCR Detection System
  • Biorad Experion™ Automated Electrophoresis Station and Agilent 2100 Bioanalyzer
  • Janus Automated Workstation
  • Nanoprint Microarray Printing
  • Modular Tissue Embedding Center Leica EG1150
  • Semi-enclosed Benchtop Tissue Processor Leica TP1020
  • Veridiam Tissue Arrayer

Core Director

Kar-Ming Fung, MD, PhD

Forms

Stephenson Cancer Center uses iLab for online scheduling for shared resources.
Use iLab to access this core >

Usage Acknowledgement

If research supported by Stephenson Cancer Center core facilities results in a publication or news release, please acknowledge this support in your manuscript. Following publication, please send us one of your reprints for our records.